A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis

S Yang, S Chu, Y Gao, Q Ai, Y Liu, X Li, N Chen - Cells, 2019 - mdpi.com
Many cancer patients suffer from severe fatigue when treated with chemotherapy or
radiotherapy; however, the etiology and pathogenesis of this kind of fatigue remains …

Cancer cachexia: Diagnosis, assessment, and treatment

M Sadeghi, M Keshavarz-Fathi, V Baracos… - Critical reviews in …, 2018 - Elsevier
Cancer cachexia is a multi-factorial syndrome, which negatively affects quality of life,
responsiveness to chemotherapy, and survival in advanced cancer patients. Our …

Diagnosis and outcomes of cachexia in Asia: working consensus report from the Asian Working Group for Cachexia

H Arai, K Maeda, H Wakabayashi… - Journal of cachexia …, 2023 - Wiley Online Library
Chronic diseases often lead to metabolic disorders, causing anabolic resistance and
increased energy consumption, which result in cachexia. Cachexia, in turn, can lead to …

Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?

A Dolly, JF Dumas, S Servais - Journal of Cachexia …, 2020 - Wiley Online Library
Research investigators have shown a growing interest in investigating alterations underlying
skeletal muscle wasting in patients with cancer. However, skeletal muscle dysfunctions …

Cachexia in cancer: what is in the definition?

G Vanhoutte, M van de Wiel… - BMJ open …, 2016 - bmjopengastro.bmj.com
Objective This study aimed to provide evidence-based results on differences in overall
survival (OS) rate to guide the diagnosis of cancer cachexia. Design Data collection and …

Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia–can findings from animal models be translated to humans?

TC Mueller, J Bachmann, O Prokopchuk, H Friess… - BMC cancer, 2016 - Springer
Background Cachexia is a multi-factorial, systemic syndrome that especially affects patients
with cancer of the gastrointestinal tract, and leads to reduced treatment response, survival …

Obesity, adipokines and cancer: an update

CH Lee, YC Woo, Y Wang, CY Yeung… - Clinical …, 2015 - Wiley Online Library
Obesity causes dysfunction of adipose tissue, with resultant chronic inflammation and
adverse interplay of various adipokines, sex steroids and endocrine hormones. All these …

Cancer as a proinflammatory environment: metastasis and cachexia

N Inácio Pinto, J Carnier, LM Oyama… - Mediators of …, 2015 - Wiley Online Library
The development of the syndrome of cancer cachexia and that of metastasis are related with
a poor prognostic for cancer patients. They are considered multifactorial processes …

[HTML][HTML] Effects of ruxolitinib treatment on metabolic and nutritional parameters in patients with myelofibrosis from COMFORT-I

RA Mesa, S Verstovsek, V Gupta… - … Myeloma and Leukemia, 2015 - Elsevier
Abstract Background In the COMFORT (COntrolled MyeloFibrosis Study with ORal JAK
Inhibitor Therapy)-I study, the Janus kinase (JAK) 1/JAK2 inhibitor ruxolitinib provided …

Targeting inflammation in non-small cell lung cancer through drug repurposing

T Rajasegaran, CW How, A Saud, A Ali, JCW Lim - Pharmaceuticals, 2023 - mdpi.com
Lung cancer is the most common cause of cancer-related deaths. Lung cancers can be
classified as small-cell (SCLC) or non-small cell (NSCLC). About 84% of all lung cancers …